Chemotherapy is treatment of cancer with anticancer drugs. Chemotherapy is administered in different ways, depending on the drugs to be given and the type of cancer. Doctors decide the dose of chemotherapy drugs considering many factors, among them being the patient’s height and weight.
Fewer than half of breast cancer patients adhere to hormonal therapy regimen, study finds – A new study of nearly 8,800 women with early-stage breast cancer found that fewer than half ? approximately 49 percent ? completed their full regimen of hormone therapy according to the prescribed schedule.
Miami meeting on radiation therapy targets patient safety — Gathering brings clinicians, manufacturers, regulators, hospital administrators and public interest groups together to discuss new ways of avoiding errors – A meeting in Miami this week will bring together some of the world’s leading experts from inside and outside the clinic to discuss safety in radiation therapy — a critical method for treating cancer.
Vaccine hope for skin cancer sufferers – Nottingham scientists have been given the green light to test a vaccine which they hope could reverse, and even cure malignant melanoma, the most deadly type of skin cancer.
Novel anti-malarial drug candidate found by UT Southwestern researchers – As part of a multicenter study, UT Southwestern Medical Center researchers have identified a series of chemical compounds that might serve as starting points for the identification of new classes of anti-malarial drugs.
Exercise may keep cancer patients healthier during, after treatment – Breast and prostate cancer patients who regularly exercise during and after cancer treatment report having a better quality of life and being less fatigued, according to researchers at Henry Ford Hospital in Detroit.
Dietary supplements discouraged for prostate cancer patients during radiation therapy treatments – Prostate-specific dietary supplements should not be taken during radiation therapy treatments because they have been shown to increase the radiosensitivity of normal prostate cell lines, leading to normal tissue complications.
Delaying post-surgical radiation increases risk of breast cancer recurrence in older women – Older women who have had breast cancer surgery have a greater risk of the cancer returning if they delay their post-surgical radiation treatment, report Dana-Farber Cancer Institute scientists.
Testosterone deficiency affects male cancer survivors’ quality of life – A new study has found that many male cancer survivors who develop testosterone deficiency after receiving chemotherapy or radiation therapy have an impaired quality of life and reduced energy levels.
Personalizing cancer: Creating biomarkers from tumor DNA – Researchers have developed a new technique for tracking cancer by identifying personalized biomarkers from tumor DNA, reports a new study in the 24 February 2010 issue of the journal Science Translational Medicine, published by AAAS, the nonprofit science society.
FDA Announces New Safety Plan for Agents Used to Treat Chemotherapy-Related Anemia – The U.S. Food and Drug Administration today approved a risk management program to inform healthcare providers and their patients about the risks of a class of drugs called Erythropoiesis-Stimulating Agents (ESAs).
Genes found linked to breast cancer drug resistance could guide future treatment choices – Researchers at Dana-Farber Cancer Institute have discovered a gene activity signature that predicts a high risk of cancer recurrence in certain breast tumors that have been treated with commonly used chemotherapy drugs.
Mayo Clinic researchers say breast cancer survival improves Herceptin used with chemotherapy – Using Herceptin with chemotherapy clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher.
